Skip to contentVIKING GLOBAL INVESTORS LP — APi Group Corp insider: 26 transactions · InsiderLensVIKING GLOBAL INVESTORS LP
- 10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
- 10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
- 10% owner at APi Group Corp · on record since Mar 7, 2024
- 10% owner at TASER INTERNATIONAL INC · on record since Jul 13, 2016
- 10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
- 10% owner at Glori Energy Inc. · on record since Jun 7, 2024
- 10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
- 10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
- 10% owner at Wayfair Inc. · on record since Nov 24, 2014
- 10% owner at FIRST DATA CORP · on record since Oct 15, 2015
- Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
- 10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
- 10% owner at FIGS, Inc. · on record since Jun 7, 2021
- 10% owner at GENENTECH INC · on record since Sep 23, 2021
- 10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
- 10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
- 10% owner at ADAPTEC INC · on record since Jun 26, 2019
- Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
- Former 10% Owner at TASER INTERNATIONAL INC · on record since Jul 12, 2019
- Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
- Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019
- 10% owner at ADVANCED PHOTONIX INC · on record since Apr 28, 2020
- 10% owner at Zentalis Pharmaceuticals, Inc. · on record since Apr 8, 2020
- 10% owner at Inhibrx Biosciences, Inc. · on record since Aug 28, 2020
- 10% owner at Rallybio Corp · on record since Jul 29, 2021
- 10% owner at 4D Molecular Therapeutics, Inc. · on record since Dec 17, 2020
- 10% owner at PROCEPT BioRobotics Corp · on record since Sep 21, 2021
- 10% owner at Roivant Sciences Ltd. · on record since Oct 1, 2021
- 10% owner at Amylyx Pharmaceuticals, Inc. · on record since Jan 13, 2022
- 10% owner at Frazier Lifesciences Acquisition Corp · on record since Nov 25, 2022
Insider trading activity of VIKING GLOBAL INVESTORS LP
- Transactions on record
- 26
- since Nov 24, 2014
- Open-market buys
- 13
- $26.1M
- Open-market sells
- 3
- $203.5M
- Companies traded
- 5
- last filing Jun 3, 2024
Figures computed from official regulatory filings — methodology.
Companies where VIKING GLOBAL INVESTORS LP has traded
Track record of VIKING GLOBAL INVESTORS LP
Statistical track record
Free- Open-market buys
- 13
- Last buy
- Aug 25, 2020
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of VIKING GLOBAL INVESTORS LP
Co-insiders of VIKING GLOBAL INVESTORS LP
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
4D Molecular Therapeutics, Inc. +13
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 3, 2024 | Other | -6,305,866 | 30.00 USD | $189.2M | SEC |
| Jun 3, 2024 | Other | -333,333 | 30.00 USD | $10M | SEC |
| Jun 3, 2024 | OtherD | -1,038,765 | 30.00 USD | $31.2M | SEC |
| Jun 3, 2024 | Other | -511,627 | 30.00 USD | $15.3M | SEC |
| Mar 1, 2024 | OtherD | -196,000 | 0.00 USD | $0 | SEC |
| Mar 1, 2024 | OtherD | -4,000 | 0.00 USD | $0 | SEC |
| Mar 1, 2024 | Other | -3,983,739 | 36.90 USD | $147M | SEC |
| Mar 1, 2024 | Other | 164,016 | 24.60 USD | $4M | SEC |
| Mar 1, 2024 | Other | -81,300 | 36.90 USD | $3M | SEC |
| Mar 1, 2024 | Other | 8,036,862 | 24.60 USD | $197.7M | SEC |
| Jan 4, 2024 | Sell | -6,300,817 | 31.30 USD | $197.2M | SEC |
| Jan 4, 2024 | Sell | -195,200 | 31.30 USD | $6.1M | SEC |
| Jan 4, 2024 | Sell | -3,983 | 31.30 USD | $124.7K | SEC |
| Aug 25, 2020 | Buy | 70,479 | 19.39 USD | $1.4M | SEC |
| Aug 25, 2020 | Buy | 46,161 | 19.43 USD | $896.9K | SEC |
| Aug 25, 2020 | Buy | 14,825 | 19.23 USD | $285.1K | SEC |
| Jun 3, 2019 | Buy | 5,424 | 7.71 USD | $41.8K | SEC |
| Jun 3, 2019 | Buy | 300 | 8.91 USD | $2.7K | SEC |
| Jun 3, 2019 | Buy | 6,951 | 7.97 USD | $55.4K | SEC |
| Jun 3, 2019 | Buy | 5,071 | 7.70 USD | $39K | SEC |
| May 29, 2019 | Buy | 3,796 | 7.70 USD | $29.2K | SEC |
| May 29, 2019 | Buy | 6,882 | 7.55 USD | $52K | SEC |
| May 29, 2019 | Buy | 3,807 | 7.68 USD | $29.2K | SEC |
| Apr 5, 2018 | Buy | 1,110,015 | 20.27 USD | $22.5M | SEC |
| Nov 24, 2014 | Buy | 17,600 | 22.73 USD | $400K | SEC |